Skip to main content

and
  1. No Access

    Article

    TOXICAN: a guide for grading dermatological adverse events of cancer treatments

    The dermatological toxicity of cancer treatments is frequent and sometimes debilitating. Its reference classification, the NCI-CTCAE (National Cancer Institute–Common Terminology Criteria for Adverse Events), ...

    L. Peuvrel, J. Cassecuel, C. Bernier, G. Quéreux in Supportive Care in Cancer (2018)

  2. No Access

    Article

    Changes in quality of life after a diagnosis of cancer: a 2-year study comparing breast cancer and melanoma patients

    Longitudinal studies addressing change in health-related quality of life (HRQoL) following a diagnosis of cancer have mainly focused on a single cancer type, and little is known about the differences in HRQoL...

    M. Bourdon, M. Blanchin, P. Tessier, M. Campone, G. Quéreux in Quality of Life Research (2016)

  3. No Access

    Article

    Incidence and characteristics of melanoma brain metastases develo** during treatment with vemurafenib

    Vemurafenib is indicated for the treatment of patients with BRAF V600 -mutant metastatic melanoma. We studied for the first time the characteristics of brain met...

    L. Peuvrel, M. Saint-Jean, G. Quéreux, A. Brocard, A. Khammari in Journal of Neuro-Oncology (2014)

  4. No Access

    Article

    Spiritualité et changement de valeurs chez des patients atteints d’un mélanome: une étude qualitative exploratoire

    Au coeur de débats théoriques et méthodologiques, la spiritualité est un concept psychologique qui suscite depuis quelques années un intérêt grandissant en santé. Dans le but de conduire un travail de recherch...

    M. Bourdon, A. Bonnaud-Antignac, N. Roussiau, G. Quéreux in Psycho-Oncologie (2011)